InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| Normocin® - Antimicrobial Reagent | dCas9-mediated dysregulation of gene expression in human induced pluripotent ... | 2022 | Metab Eng. | Haellman V. et al. | DOI: 10.1016/j.ymben.2022.06.003 |
| Puromycin | MALAT1-dependent hsa_circ_0076611 regulates translation rate in triple-negati... | 2022 | Commun Biol. | Turco C. et al. | DOI: 10.1038/s42003-022-03539-x |
| Alhydrogel® adjuvant 2% | Neuraminidase (NA) 370-Loop Mutations of the 2009 Pandemic H1N1 Viruses Affec... | 2022 | Viruses | Chen T.H. et al. | DOI: 10.3390/v14061304 |
| Alhydrogel® adjuvant 2% | Production of Neuraminidase Virus Like Particles by Stably Transformed Insect... | 2022 | Mol Biotechnol. | Khanefard N. et al. | DOI: 10.1007/s12033-022-00519-8 |
| AddaVax™ | Formulation of an ovarian cancer vaccine with the squalene-based AddaVax adju... | 2022 | Clin Exp Vaccine Res. | Mazumder S. et al. | DOI: 10.7774/cevr.2022.11.2.163 |
| G418 (Geneticin) | Therapeutic efficacy of monoclonal antibodies and antivirals against SARS-CoV... | 2022 | Nat Microbiol. | Uraki R. et al. | DOI: 10.1038/s41564-022-01170-4 |
| Plasmocin® - Mycoplasma Elimination Reagent | Therapeutic efficacy of monoclonal antibodies and antivirals against SARS-CoV... | 2022 | Nat Microbiol. | Uraki R. et al. | DOI: 10.1038/s41564-022-01170-4 |
| Jurkat Reporter Cells (NFAT) | Arginine-based cationic liposomes accelerate T cell activation and differenti... | 2022 | Int J Pharm. | Li T. et al. | DOI: 10.1016/j.ijpharm.2022.121917 |
| pDRIVE-Survivin | Development of a cancer cells self‑activating and miR‑125a‑5p expressing poly... | 2022 | Int J Mol Med. | Chang Y.C. et al. | DOI: 10.3892/ijmm.2022.5158 |
| Puromycin | Protocol to isolate and assess spike protein cleavage in SARS-CoV-2 variants ... | 2022 | STAR Protoc. | Escalera A. et al. | DOI: 10.1016/j.xpro.2022.101502 |
| Normocin® - Antimicrobial Reagent | Protocol to isolate and assess spike protein cleavage in SARS-CoV-2 variants ... | 2022 | STAR Protoc. | Escalera A. et al. | DOI: 10.1016/j.xpro.2022.101502 |
| Blasticidin | A simulation model of heterochromatin formation at submolecular detail. | 2022 | iScience | Williams M.R. et al. | DOI: 10.1016/j.isci.2022.104590 |
| Puromycin | A simulation model of heterochromatin formation at submolecular detail. | 2022 | iScience | Williams M.R. et al. | DOI: 10.1016/j.isci.2022.104590 |
| Puromycin | Functional genomics screening identifies aspartyl-tRNA synthetase as a novel ... | 2022 | J Pathol. | Liu B. et al. | DOI: 10.1002/path.5980 |
| Mouse TLR9 Reporter HEK293 Cells (NF-κB) | Regional infusion of a class C TLR9 agonist enhances liver tumor microenviron... | 2022 | Cancer Gene Ther. | Ghosh C.C. et al. | DOI: 10.1038/s41417-022-00484-z |
| ODN 2395 control | Regional infusion of a class C TLR9 agonist enhances liver tumor microenviron... | 2022 | Cancer Gene Ther. | Ghosh C.C. et al. | DOI: 10.1038/s41417-022-00484-z |
| ODN 2395 - TLR9 ligand | Regional infusion of a class C TLR9 agonist enhances liver tumor microenviron... | 2022 | Cancer Gene Ther. | Ghosh C.C. et al. | DOI: 10.1038/s41417-022-00484-z |
| Alpha Variant (B.1.1.7) Spike Expression Vectors | Inactivated whole-virion vaccine BBV152/Covaxin elicits robust cellular immun... | 2022 | Nat Microbiol | Vikkurthi R. et al. | DOI: 10.1038/s41564-022-01161-5 |
| Beta Variant (B.1.351) Spike Expression Vectors | Inactivated whole-virion vaccine BBV152/Covaxin elicits robust cellular immun... | 2022 | Nat Microbiol | Vikkurthi R. et al. | DOI: 10.1038/s41564-022-01161-5 |
| 2'3'-cGAMP VacciGrade™ | Activating cGAS-STING axis contributes to neuroinflammation in CVST mouse mod... | 2022 | J Neuroinflammation | Ding R. et al. | DOI: 10.1186/s12974-022-02511-0 |